TREM-1 and pentraxin-3 plasma levels and their association with obstructive sleep apnea, obesity, and endothelial function in children

Sleep

Volumn 36, Issue 6, 2013, Pages 923-931

  Kim, Jinkwan ^a   Gozal, David ^a   Bhattacharjee, Rakesh ^a   Kheirandish Gozal, Leila ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Endothelial function; Inflammation; Obesity; Obstructive sleep apnea; Pentraxin 3; Triggering receptor expressed on myeloid cells 1

Indexed keywords

PENTRAXIN 3; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

APNEA HYPOPNEA INDEX; ARTERY OCCLUSION; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; BODY MASS; BRACHIAL ARTERY OCCLUSION; CARDIOVASCULAR RISK; CHILD; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SLEEP DISORDERED BREATHING; THROMBOCYTE;

ENDOTHELIAL FUNCTION; INFLAMMATION; OBESITY; OBSTRUCTIVE SLEEP APNEA; PENTRAXIN-3; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-1;

C-REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; CHILD; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPIDS; MALE; MEMBRANE GLYCOPROTEINS; OBESITY; POLYSOMNOGRAPHY; RECEPTORS, IMMUNOLOGIC; SERUM AMYLOID P-COMPONENT; SLEEP APNEA, OBSTRUCTIVE;

EID: 84878432624     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2726     Document Type: Article

References (64)

1. Kim J, Hakim F, Kheirandish-Gozal L, Gozal D. Inflammatory pathways in children with insufficient or disordered sleep. Respir Physiol Neurobiol 2011;178:465-74.
2. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918.
3. Chami HA, Resnick HE, Quan SF, Gottlieb DJ. Association of incident cardiovascular disease with progression of sleep-disordered breathing. Circulation 2011;123:1280-6.
4. Gozal D, Kheirandish-Gozal L, Bhattacharjee R, Spruyt K. Neurocognitive and endothelial dysfunction in children with obstructive sleep apnea. Pediatrics 2010;126:e1161-7.
5. Tessarz AS, Cerwenka A. The TREM-1/DAP12 pathway. Immunol Lett 2008;116:111-6.
6. Klesney-Tait J, Turnbull IR, Colonna M. The TREM receptor family and signal integration. Nat Immunol 2006;7:1266-73. (Pubitemid 46111244)
7. Morales J, Villa K, Gattis J, et al. Soluble TLT-1 modulates platelet-endothelial cell interactions and actin polymerization. Blood Coagul Fibrinolysis 2010;21:229-36.
8. Hermus L, Schuitemaker JH, Tio RA, et al. Novel serum biomarkers in carotid artery stenosis: useful to identify the vulnerable plaque? Clin Biochem 2011;44:1292-8.
9. Deban L, Jaillon S, Garlanda C, Bottazzi B, Mantovani A. Pentraxins in innate immunity: lessons from PTX3. Cell Tissue Res 2010;343:237-49.
10. Garlanda C, Bottazzi B, Moalli F, et al. Pentraxins and atherosclerosis: the role of PTX3. Curr Pharm Des 2011;17:38-46.
11. Kunes P, Holubcova Z, Kolackova M, Krejsek J. Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response. Mediators Inflamm 2012;2012:920517.
12. Kasai T, Inoue K, Kumagai T, et al. Plasma pentraxin3 and arterial stiffness in men with obstructive sleep apnea. Am J Hypertens 2011;24:401-7.
13. Gozal D, Kheirandish-Gozal L, Serpero LD, Sans Capdevila O, Dayyat E. Obstructive sleep apnea and endothelial function in school-aged nonobese children: effect of adenotonsillectomy. Circulation 2007;116:2307-14. (Pubitemid 350100337)
14. Montgomery-Downs HE, O'Brien LM, Gulliver TE, Gozal D. Polysomnographic characteristics in normal preschool and early school-aged children. Pediatrics 2006;117:741-53. (Pubitemid 46063216)
15. Standards and indications for cardiopulmonary sleep studies in children. American Thoracic Society. Am J Respir Crit Care Med 1996;153:866-78.
16. Rechstschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Brain Information Services/Brain Research Institute, University of California, Los Angeles, 1968.
17. Schulz H. Phasic or transient? Comment on the terminology of the AASM manual for the scoring of sleep and associated events. J Clin Sleep Med 2007;3:752. (Pubitemid 351204507)
18. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-84.
19. Bhattacharjee R, Kim J, Alotaibi WH, Kheirandish-Gozal L, Capdevila OS, Gozal D. Endothelial dysfunction in children without hypertension: potential contributions of obesity and obstructive sleep apnea. Chest 2012;141:682-91.
20. Wahlberg E, Olofsson P, Swendenborg J, Fagrell B. Changes in postocclusive reactive hyperaemic values as measured with laser Doppler fluxmetry after infrainguinal arterial reconstructions. Eur J Vasc Endovasc Surg 1995;9:197-203.
21. Kim J, Bhattacharjee R, Kheirandish-Gozal L, Spruyt K, Gozal D. Circulating microparticles in children with sleep disordered breathing. Chest 2011;140:408-17.
22. Kim J, Bhattacharjee R, Snow AB, Capdevila OS, Kheirandish-Gozal L, Gozal D. Myeloid-related protein 8/14 levels in children with obstructive sleep apnoea. Eur Respir J 2010;35:843-50.
23. Wang Y, Zhang SX, Gozal D. Reactive oxygen species and the brain in sleep apnea. Respir Physiol Neurobiol 2011;174:307-16.
24. Lavie L, Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 2009;33:1467-84.
25. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009;32:447-70.
26. Gozal D, Kheirandish-Gozal L, Bhattacharjee R, Kim J. C-reactive protein and obstructive sleep apnea syndrome in children. Front Biosci (Elite Ed) 2012;4:2410-22.
27. Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol 2003;3:445-53. (Pubitemid 37339184)
28. Gibot S. Clinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis. Crit Care 2005;9:485-9. (Pubitemid 41498545)
29. Murakami Y, Akahoshi T, Aoki N, Toyomoto M, Miyasaka N, Kohsaka H. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis. Arthritis Rheum 2009;60:1615-23.
30. Radsak MP, Taube C, Haselmayer P, et al. Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol 2007;2007:52040.
31. Bosco MC, Pierobon D, Blengio F, et al. Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood 2011;117:2625-39.
32. Norata GD, Garlanda C, Catapano AL. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc Med 2010;20:35-40.
33. Cieslik P, Hrycek A. Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications. Autoimmunity 2012;45:119-28.
34. Can M, Acikgoz S, Mungan G, et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006;129:233-7. (Pubitemid 43289839)
35. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-34. (Pubitemid 36297204)
36. Tauman R, Ivanenko A, O'Brien LM, Gozal D. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004;113:e564-9.
37. Li AM, Chan MH, Yin J, et al. C-reactive protein in children with obstructive sleep apnea and the effects of treatment. Pediatr Pulmonol 2008;43:34-40.
38. Kheirandish-Gozal L, Capdevila OS, Tauman R, Gozal D. Plasma C-reactive protein in nonobese children with obstructive sleep apnea before and after adenotonsillectomy. J Clin Sleep Med 2006;2:301-4. (Pubitemid 44299553)
39. Goldbart AD, Levitas A, Greenberg-Dotan S, et al. B-type natriuretic peptide and cardiovascular function in young children with obstructive sleep apnea. Chest 2010;138:528-35.
40. Barcelo A, Barbe F, Llompart E, et al. Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 2004;117:118-21. (Pubitemid 38953732)
41. Guilleminault C, Kirisoglu C, Ohayon MM. C-reactive protein and sleep-disordered breathing. Sleep 2004;27:1507-11. (Pubitemid 40041619)
42. Kaditis AG, Alexopoulos EI, Kalampouka E, et al. Morning levels of Creactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 2005;171:282-6.
43. Tam CS, Wong M, McBain R, Bailey S, Waters KA. Inflammatory measures in children with obstructive sleep apnoea. J Paediatr Child Health 2006;42:277-82. (Pubitemid 43736365)
44. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997;272:9496-502. (Pubitemid 27154966)
45. Guignard F, Mauel J, Markert M. Phosphorylation of myeloid-related proteins MRP-14 and MRP-8 during human neutrophil activation. Eur J Biochem 1996;241:265-71. (Pubitemid 26342998)
46. Croce K, Gao H, Wang Y, et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 2009;120:427-36.
47. Schaub N, Reichlin T, Meune C, et al. Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. Clin Chem 2012;58:246-56.
48. Deban L, Jaillon S, Garlanda C, Bottazzi B, Mantovani A. Pentraxins in innate immunity: lessons from PTX3. Cell Tissue Res 2011;343:237-49.
49. Deban L, Russo RC, Sironi M, et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol 2011;11:328-34.
50. Gozal D, Capdevila OS, Kheirandish-Gozal L. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med 2008;177:1142-9. (Pubitemid 351717574)
51. Peri G, Introna M, Corradi D, et al. PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 2000;102:636-41. (Pubitemid 30640663)
52. Latini R, Maggioni AP, Peri G, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004;110:2349-54. (Pubitemid 39407338)
53. Inoue K, Sugiyama A, Reid PC, et al. Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 2007;27:161-7. (Pubitemid 46360394)
54. Matsui S, Ishii J, Kitagawa F, et al. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis 2010;210:220-5.
55. Brugger-Andersen T, Ponitz V, Kontny F, et al. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain. Thromb Haemost 2009;102:555-63.
56. Ogawa T, Kawano Y, Imamura T, et al. Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome. Obesity (Silver Spring) 2010;18:1871-4.
57. Miyaki A, Maeda S, Yoshizawa M, et al. Is pentraxin 3 involved in obe-sity- induced decrease in arterial distensibility? J Atheroscler Thromb 2010;17:278-84.
58. Dursun I, Poyrazoglu HM, Gunduz Z, et al. The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease. Nephrol Dial Transplant 2009;24:2511-8.
59. Chen Y, Feng B, Li X, Ni Y, Luo Y. Plasma endothelial microparticles and their correlation with the presence of hypertension and arterial stiffness in patients with type 2 diabetes. J Clin Hypertens (Greenwich) 2012;14:455-60.
60. Kim J, Bhattacharjee R, Khalyfa A, et al. DNA methylation in inflammatory genes among children with obstructive sleep apnea. Am J Respir Crit Care Med 2012;185:330-8.
61. Kent BD, Ryan S, McNicholas WT. The genetics of obstructive sleep apnoea. Curr Opin Pulm Med 2010;16:536-42.
62. Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 2009;21:38-46.
63. Gozal D. Serum, urine, and breath-related biomarkers in the diagnosis of obstructive sleep apnea in children: is it for real? Curr Opin Pulm Med 2012;18:561-7.
64. Dominguez-Rodriguez A, Abreu-Gonzalez P, Kaski JC. Inflammatory systemic biomarkers in setting acute coronary syndromes - effects of the diurnal variation. Curr Drug Targets 2009;10:1001-8.